Sign In

Elin Haf Davies

CEO at Aparito - wholly owned subsidiary of Eli Lilly and Company

Elin Haf Davies is an accomplished professional with a diverse background in nursing, academia, regulation, and entrepreneurship.

Having obtained a BSc, MSc, and PhD, Elin founded Aparito in 2014, a company focused on revolutionizing clinical trials by digitizing processes and accelerating drug development for life-limiting diseases.

Her passion for patient-centric healthcare led to the creation of Atom5TM, a platform aimed at improving the accessibility of clinical trials to all stakeholders.

Elin's dedication to addressing the needs of patients, healthcare providers, regulators, and reimbursement agencies underscores her commitment to enhancing the clinical trial experience.

Outside of her professional endeavors, Elin finds solace in ocean adventures, using her experiences to raise funds for charitable causes that are close to her heart.

Her challenging feats, including rowing across the Atlantic and Indian oceans and sailing across the Pacific and Atlantic, reflect her resilience and determination.

Elin draws parallels between her oceanic voyages and the challenges inherent in rare disease drug development, emphasizing the personal journeys individuals undergo in the quest for better healthcare solutions.

By integrating her extreme adventures with her professional career, Elin gains unique perspectives that contribute to her growth and enrich her approach to problem-solving.

Elin Haf Davies
Add to my network

Location

London, England, United Kingdom